Back to News
Market Impact: 0.05
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Source: zacks.com
Healthcare & Biotech
The Invesco Biotechnology & Genome ETF (PBE) debuted on June 23, 2005. The article describes it as a smart-beta ETF offering broad exposure to the Health Care ETF category.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
- Supernus Pharmaceuticals stock hits 52-week low at 40.5 USD
- Top biotechnology stock pick from Guggenheim
- Liquidia shares surge 25% as settlement ends United Therapeutics litigation
- Needham raises Starling Oncology stock price target on growth outlook
- Why is Olympus stock plunging today?